Clinical Trial Update: Indocyanine Green for Central Nervous System Tumors [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating indocyanine green for suspected central nervous system tumors; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Tumors

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Suspected Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-10-27